首页> 美国卫生研究院文献>Pharmaceutics >Different BCS Class II Drug-Gelucire Solid Dispersions Prepared by Spray Congealing: Evaluation of Solid State Properties and In Vitro Performances
【2h】

Different BCS Class II Drug-Gelucire Solid Dispersions Prepared by Spray Congealing: Evaluation of Solid State Properties and In Vitro Performances

机译:通过喷涂凝结制备的不同BCS II类药物 - Gelucire固体分散体:固态性能和体外性能的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Delivery of poorly water soluble active pharmaceutical ingredients (APIs) by semi-crystalline solid dispersions prepared by spray congealing in form of microparticles (MPs) is an emerging method to increase their oral bioavailability. In this study, solid dispersions based on hydrophilic Gelucires® (Gelucire® 50/13 and Gelucire® 48/16 in different ratio) of three BCS class II model compounds (carbamazepine, CBZ, tolbutamide, TBM, and cinnarizine, CIN) having different physicochemical properties (logP, pKa, Tm) were produced by spray congealing process. The obtained MPs were investigated in terms of morphology, particles size, drug content, solid state properties, drug-carrier interactions, solubility, and dissolution performances. The solid-state characterization showed that the properties of the incorporated drug had a profound influence on the structure of the obtained solid dispersion: CBZ recrystallized in a different polymorphic form, TBM crystallinity was significantly reduced as a result of specific interactions with the carrier, while smaller crystals were observed in case of CIN. The in vitro tests suggested that the drug solubility was mainly influenced by carrier composition, while the drug dissolution behavior was affected by the API solid state in the MPs after the spray congealing process. Among the tested APIs, TBM-Gelucire dispersions showed the highest enhancement in drug dissolution as a result of the reduced drug crystallinity.
机译:通过以微粒(MPS)的喷雾凝结制备的半结晶固体分散体递送较差的水溶性活性药物成分(API)是一种新兴的方法,以增加口服生物利用度。在该研究中,基于亲水性Gelucires®(Gelucire®50/13和Gelucire的Gelucire®48/16的固体分散体为三种BCS II类模型化合物(Carbamazepine,CBZ,甲丁酰胺,TBM和Cinnarizine,Cin)不同物理化学性质(LOMP,PKA,TM)由喷涂凝结过程产生。在形态,颗粒尺寸,药物含量,固态性质,药物载体相互作用,溶解度和溶解性方面研究了所得的MPS。固态表征显示,掺入药物的性质对所得固体分散体的结构具有深远的影响:CBZ以不同的多态形式重结晶,由于与载体的特异性相互作用,TBM结晶度显着降低在CIC的情况下观察到较小的晶体。体外试验表明,药物溶解度主要受载体组合物的影响,而药物溶解行为受喷涂过程后MPS中的API固态的影响。在测试的API中,TBM-Gelucire分散体由于降低的药物结晶度而显示出药物溶解的最高增强。

著录项

  • 期刊名称 Pharmaceutics
  • 作者单位
  • 年(卷),期 2020(12),6
  • 年度 2020
  • 页码 548
  • 总页数 19
  • 原文格式 PDF
  • 正文语种
  • 中图分类 药学;
  • 关键词

    机译:微粒;喷雾冷却;喷雾冷却;gelucire;半晶硅酰胺;carbamazepine;托尔巴顿胺;cinnarizine;

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号